Back to today’s briefing

Story perspectives

New RSV Vaccine Available for Infants Starting October 1

10/14/2025

24 3

Summary

Story summary

Nirsevimab (Beyfortus®) is now available to protect infants from RSV.
RSV is a leading cause of hospitalization for children under five and spreads easily.
It has been tested for over a decade and is safe for infants from one day old.
The vaccine significantly reduces RSV pneumonia-related hospitalizations.
Parents should consult their pediatricians, and clinics will offer the vaccine starting October 1, especially for infants under eight months.

1 of 1

Story summary

Nirsevimab (Beyfortus®) is now available to protect infants from RSV.
RSV is a leading cause of hospitalization for children under five and spreads easily.
It has been tested for over a decade and is safe for infants from one day old.
The vaccine significantly reduces RSV pneumonia-related hospitalizations.
Parents should consult their pediatricians, and clinics will offer the vaccine starting October 1, especially for infants under eight months.